(Q36576467)

English

Tocilizumab attenuates inflammation in ALS patients through inhibition of IL6 receptor signaling.

scientific article published on 21 November 2012

Statements

Tocilizumab attenuates inflammation in ALS patients through inhibition of IL6 receptor signaling (English)

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit